Georgios N Dalekos

31PUBLICATIONS
139CO-AUTHORS
PharmacogenomicsDisease surveillanceHumoural immunology and immunochemistryRegenerative medicine (incl. stem cells)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Apr 13, 2026
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.

Stuart C Gordon, Alejandra Villamil, Ira M Jacobson

|Oct 22, 2025
Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R-LIVER).

A Gerussi, E Nofit, D P Bernasconi

|Jul 15, 2025
IgG Baseline Serum Levels and Prognosis of Primary Biliary Cholangitis.

Eirini I Rigopoulou, Stella Gabeta, Vasiliki Lygoura

|Jun 16, 2025
HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis D.

Margarita Papatheodoridi, Vasilios Sevastianos, Kalliopi Zachou

|Mar 24, 2025
Increased IgG Levels at Diagnosis Are Associated With Worse Prognosis of Patients With Primary Biliary Cholangitis.

Eirini I Rigopoulou, Vassiliki Lygoura, Stella Gabeta

|Nov 27, 2024
The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial.

Apostolis Papaefthymiou, Styliani Sarrou, Konstantinos Pateras

Pageof 6